BMY-14802

From WikiMD.org
Jump to navigation Jump to search

BMY-14802

BMY-14802 (pronunciation: B-M-Y-1-4-8-0-2), also known as alpha-ethyltryptamine, is a pharmacological compound with potential antipsychotic properties. It is a derivative of the naturally occurring amino acid tryptophan.

Etymology

The name BMY-14802 is derived from the compound's original designation in the research laboratories of Bristol-Myers Squibb, a leading pharmaceutical company. The compound was the 14,802nd synthesized in their labs, hence the numerical part of the name.

Pharmacology

BMY-14802 is a sigma receptor antagonist. Sigma receptors are a class of proteins found in the central nervous system that are thought to be involved in a variety of psychiatric disorders. By blocking these receptors, BMY-14802 may help to alleviate symptoms of these disorders.

Related Terms

  • Antipsychotic: A class of medication primarily used to manage psychosis, including delusions, hallucinations, paranoia, or disordered thought.
  • Sigma receptor: A class of proteins found in the central nervous system that are thought to be involved in a variety of psychiatric disorders.
  • Central nervous system: The part of the nervous system consisting of the brain and spinal cord.
  • Bristol-Myers Squibb: A leading pharmaceutical company.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski